Celldex Therapeutics
CLDX
#3753
Rank
HK$21.30 B
Marketcap
HK$321.47
Share price
0.19%
Change (1 day)
56.52%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -HK$18.81

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$18.71. In 2022 the company made an earnings per share (EPS) of -HK$18.63 a decrease over its 2021 EPS that were of -HK$12.78.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$18.810.97%
2022-HK$18.6345.73%
2021-HK$12.78-23.36%
2020-HK$16.68-41.05%
2019-HK$28.30-76.95%
2018-HK$122.7745.03%
2017-HK$84.65-42.54%
2016-HK$147.33-3.82%
2015-HK$153.17-0.76%
2014-HK$154.3429.41%
2013-HK$119.260%
2012-HK$119.26-9.73%
2011-HK$132.131312.5%
2010-HK$9.35-95.79%
2009-HK$221.98-49.64%
2008-HK$440.81-82.64%
2007-HK$2,540-44.98%
2006-HK$4,6161270.83%
2005-HK$336.7533.33%
2004-HK$252.56-10%
2003-HK$280.62-16.67%
2002-HK$336.75-38.46%
2001-HK$547.21-4.88%
2000-HK$575.27-81.66%
1999-HK$3,136-87.2%
1998-HK$24,490206.39%
1997-HK$7,99313.02%
1996-HK$7,072

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$31.26 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$6.63-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$94.16 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$110.30-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.50-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.29-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$4.44-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA